JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE) ›› 2021, Vol. 41 ›› Issue (7): 891-897.doi: 10.3969/j.issn.1674-8115.2021.07.007

• Basic research • Previous Articles    

Degradation of BCR-ABL fusion protein in chronic myeloid leukemia cells induced by isoalantolactone

Chen CHEN(), Feng-hou GAO()   

  1. Department of Oncology, Shanghai Ninth People′s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201999, China
  • Online:2021-07-28 Published:2021-08-03
  • Contact: Feng-hou GAO E-mail:chenchen951226@163.com;fenghougao@163.com
  • Supported by:
    Scientific Research Project of Science and Technology Commission of Shanghai Municipality(14401901500)

Abstract: Objective

·To explore the effect of isoalantolactone (Iso) on imatinib-sensitive and drug-resistant chronic myeloid leukemia (CML) cells, and the molecular mechanism of down regulating BCR-ABL fusion protein.

Methods

·K562 and K562R cells were treated with different concentrations of Iso for 0, 24, 36 and 48 h, respectively. The inhibitory effect of Iso on CML cells was determined by CCK-8 method. The apoptosis of K562 and K562R cells induced by Iso for 24 h was detected by flow cytometry. CML cells were treated with different concentration of Iso for different time, and the effect of Iso on the level of BCR-ABL fusion protein was detected by Western blotting. The effect of Iso on BCR-ABL mRNA level in CML cells was detected by reverse transcription and quantitative real-time PCR (qPCR). K562 cells were treated with proteasome inhibitor MG132, autophagy inhibitor 3-methyladenine and lysosomal inhibitor chloroquine combined with Iso, respectively, and K562 and K562R cells were treated with caspase inhibitor Z-VAD-FMK combined with Iso. The level of BCR-ABL fusion protein was detected by Western blotting. Caspase 3 (CASP3) and caspase 7 (CASP7) were knocked down in K562R cells, and their effects on the down-regulation of BCR-ABL fusion protein induced by Iso were detected.

Results

·The proliferation of CML cells was inhibited by Iso in a dose- and time-dependent manner. Flow cytometry showed that Iso could increase the apoptosis of K562 and K562R cells (both P<0.05). Western blotting showed that Iso could induce the decrease of BCR-ABL fusion protein level, while qPCR showed that BCR-ABL mRNA level had no significant change. MG132, 3-methyladenine and chloroquine could not reverse the down-regulation of BCR-ABL fusion protein induced by Iso, but Z-VAD-FMK could partially reverse the down-regulation. Knockdown of CASP3 could partially reverse the degradation of BCR-ABL protein induced by Iso, while CASP7 could not.

Conclusion

·Iso can target the degradation of BCR-ABL fusion protein, which provides an experimental basis for overcoming drug resistance of CML cells.

Key words: isoalantolactone (Iso), BCR-ABL fusion protein, chronic myeloid leukemia (CML), protein degradation, caspase 3 (CASP3)

CLC Number: